Evidence map›Paper›PMID 21527903›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2011

Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics.

Y Sterner, C Törn, H-S Lee, H Larsson, C Winkler, W McLeod, K Lynch, O Simell, A Ziegler, D Schatz and 7 more

Abstract read
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Y SternerDepartment of Clinical Sciences, Lund University/CRC, University Hospital MAS, Malmö, Sweden.
C Törn
H-S Lee
H Larsson
C Winkler
W McLeod
K Lynch
O Simell
A Ziegler
D Schatz
W Hagopian
M Rewers
J-X She
J P Krischer
B Akolkar
A Lernmark
TEDDY Study Group

Funding

Data Coordinating CenterU01DK063790 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI KRISCHER, JEFFREY P · 2002 to 2006
$50.1M
The Environmental Determinants of Diabetes in Young (TEDDY0U01DK063863 · NIDDK · HOSPITAL DISTRICT OF SOUTHWEST FINLAND · PI TOPPARI, JORMA · 2003 to 2022
$13.5M
The Environmental Triggers of Diabetes (TEDDY) in SwedenU01DK063861 · NIDDK · UNIVERSITY OF WASHINGTON · PI LERNMARK, AKE · 2003 to 2022
$13.4M
THE TEDDY STUDY - COLORADO CLINICAL CENTERU01DK063821 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 2003 to 2022
$12.3M
The TEDDY Study: Georgia/Florida Clinical CenterU01DK063865 · NIDDK · MEDICAL COLLEGE OF GEORGIA (MCG) · PI MCINDOE, RICHARD A. · 2003 to 2022
$12.3M
The Environmental Determinants of Diabetes in Youth: Washington Clinical CenterU01DK063829 · NIDDK · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI HAGOPIAN, WILLIAM A. · 2003 to 2022
$11.8M
Type 1 Diabetes triggers: diet modification in neonatesU01DK063836 · NIDDK · FORSCHERGRUPPE DIABETES E. V. · PI ZIEGLER, ANETTE · 2003 to 2022
$6.2M
The Environmental Triggers of Diabetes (TEDDY)UC4DK063861 · NIDDK · LUNDS UNIVERSITET · PI LERNMARK, AKE · 2013 to 2013
$5.7M
The Environmental Determinants of Diabetes in the Young (TEDDY) StudyUC4DK063863 · NIDDK · HOSPITAL DISTRICT OF SOUTHWEST FINLAND · PI TOPPARI, JORMA · 2013 to 2013
$5.6M
The TEDDY Study: Georgia/Florida Clinical CenterUC4DK063865 · NIDDK · AUGUSTA UNIVERSITY · PI SHE, JIN-XIONG · 2013 to 2013
$5.3M
The Environmental Determinants of Diabetes in the Young (TEDDY) Colorado ClinicalUC4DK063821 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 2013 to 2013
$4.9M
The Environmental Determinants of Diabetes in Youth: Washington Clinical CenterUC4DK063829 · NIDDK · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI HAGOPIAN, WILLIAM A. · 2013 to 2013
$4.6M
NIDDK NIH HHS DK 63790NIDDK NIH HHS DK 63821NIDDK NIH HHS DK 63829NIDDK NIH HHS DK 63836NIDDK NIH HHS DK 63861NIDDK NIH HHS DK 63863NIDDK NIH HHS DK 63865NIDDK NIH HHS HHSN267200700014CNIDDK NIH HHS U01 DK063829NIDDK NIH HHS U01 DK063861NIDDK NIH HHS U01 DK063865NIDDK NIH HHS UC4 DK063821NIDDK NIH HHS UC4 DK063829NIDDK NIH HHS UC4 DK063861NIDDK NIH HHS UC4 DK063865
6 · The paper itself

Abstract

objectiveTo examine the relationship between high-risk human leukocyte antigen (HLA) genotypes for type 1 diabetes and birth size in combination with prenatal ch aracteristics in different countries. STUDY

designFour high-risk HLA genotypes were enrolled in the Environmental determinants of Diabetes in the Young study newborn babies from the general population in Finland, Germany, Sweden and the United States. Stepwise regression analyses were used to adjust for country, parental physical characteristics and environmental factors during pregnancy.

resultRegression analyses did not reveal differences in birth size between the four type 1 diabetes high-risk HLA genotypes. Compared with DQ 4/8 in each country, (1) DQ 2/2 children were heavier in the United States (P=0.028) mostly explained however, by parental weight; (2) DQ 2/8 (P=0.023) and DQ 8/8 (P=0.046) children were longer in Sweden independent of parents height and as well as (3) in the United States for DQ 2/8 (P=0.023), but again dependent on parental height.

conclusionChildren born with type 1 diabetes high-risk HLA genotypes have comparable birth size. Longitudinal follow-up of these children should reveal whether birth size differences between countries contribute to the risk for islet autoimmunity and type 1 diabetes.

Indexed as

Birth WeightBody HeightGenetic Predisposition to DiseaseGenotypeParentsBody WeightDiabetes Mellitus, Type 1FemaleFinlandGermanyHLA-DQ AntigensHumansInfant, NewbornMalePregnancyRisk FactorsHLA-DQ Antigens

Identifiers

PMID21527903
PMCPMC3226663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.